Coronavirus Plasma Treatments Begin in Major Texas Hospital System
HOUSTON, Texas — Houston Methodist Hospital received approval from the U.S. Food and Drug Administration (FDA) to begin utilizing plasma transfusions to treat COVID-19 patients. The FDA approved the major Houston hospital system as the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill one.
